Abstract

Nowadays, Heart disease is one of the crucial impacts of mortality in the country. In clinical data analysis, predicting cardiovascular disease is a primary challenge. Deep learning (DL) has been demonstrated to be effective in helping to determine and forecast a huge amount of data produced by the health industry. In this paper, the proposed Recursion enhanced random forest with an improved linear model (RFRF-ILM) to detect heart disease. This paper aims to find the key features of the prediction of cardiovascular diseases through the use of machine learning techniques. The prediction model is adding various combinations of features and various established methods of classification. it produces a better level of performance with precision through the heart disease prediction model. In this study, the factors leading to cardiovascular disease can be diagnosed. A comparison of important variables showed with the Internet of Medical Things (IoMT) platform, for data analysis. This indicates that coronary artery disease develops more often in older ages. Also important in this disease's outbreak is high blood pressure. For this purpose, measures must be taken to prevent this disease and Diabetes provides a further aspect that should be taken into consideration in the occurrence of coronary artery disease with 96.6 % accuracy,96.8% stability ratio and 96.7% F-measure ratio.

Highlights

  • Heart disease is a collection of diseases impacting the heart and veins of human beings

  • Dataset clustering is based on Decision Tree (DT) feature variables and criteria

  • The proposed RFRF-ILM method is utilized merging the features of the linear model and random forest

Read more

Summary

Introduction

Heart disease is a collection of diseases impacting the heart and veins of human beings. Several factors/parameters have been identified that cause heart disease or increase cardiac disease [3]. Most hospitals have management software for monitoring their clinical and/or patient data. In [20] Deep learning (DLTs) is designed to evaluate stable CVDs to reduce RHI mal diagnosis. This means that the CVDs need to be analyzed. The goal of this paper is, to synthesize and identify CVD patients who entered the emergency section from January (2018 to December 2019) with molecular diagnostics (MD), and with Deep Learning Techniques (DLTs)

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.